Reference projects of Fraunhofer IESE

1. FC Kaiserslautern is aiming for comprehensive digitalization measures that affect the strategic and operational business of the soccer club. Above all, FCK wants to modernize its systems and business processes holistically and take them to the next level of digitalization. The club from the Western Palatinate is relying on Fraunhofer IESE as its digitalization partner.

In the BMBF-funded DI-DERAMSys project, Fraunhofer IESE and its project partners are researching an open-source design and simulation environment for DRAM memories.

In collaboration with Balanced Engineering LLC, Fraunhofer IESE developed a concept to improve and advance the testing and development of autonomous agricultural vehicles.

In a joint “Tangible Ecosystem Design” project, the German company Würth and Fraunhofer IESE developed concrete innovation scenarios for novel digital ecosystem services for businesses in the skilled trades sector.

For Robert Bosch GmbH, Fraunhofer IESE analyzed the functional safety of the Retrofit Efficiency Module retrofit solution for logistics companies based on ISO 26262.

Fraunhofer IESE crafted a specialized tool for Robert Bosch GmbH that streamlines change impact analysis. This solution equips developers of critical systems with a comprehensive understanding of the dependencies affected by incoming change, enabling more effective prioritization of modifications to reduce subsequent impacts and accelerate the development process.

Runtime verification safety engineering methodology and proof of concept for a connected autonomous shuttle at pedestrian crossings in a Bus Rapid Transit (BRT) system.

In the project EURIDICE, Fraunhofer IESE is developing knowledge content on Digital Ecosystems and, together with European universities, start-ups, and research institutions, is building a network for the exchange of knowledge content on digital technologies.

In the publicly funded project Bridge-Up, Fraunhofer IESE is collaborating with the University of Bonn to develop a solution for implementing data provider rights and data trustee obligations – to promote data provider participation in trustee models.

Tumor-targeted drug therapy is an important part of the treatment of cancer and malignant blood diseases. Many chemotherapy regimens usually combine several active substances, and complex protocols may contain three or more substances. The individual substances are each associated with side effects. These require specific concomitant and supportive therapy. In addition to anti-tumor therapy, prophylactic drugs are integrated into the protocol as essential supportive therapy.